Literature DB >> 2810311

Clinical, biochemical and histological responses to treatment in polymyositis: a prospective study.

R J Lane1, A Emslie-Smith, I E Mosquera, P Hudgson.   

Abstract

Routine methods of monitoring treatment responses in polymyositis patients, such as clinical strength assessments and measurements of ESR and serum creatine kinase, have been compared with functional strength measurements and assay of serum myoglobin levels, in a prospective study of nine cases followed for up to five years. Seven patients also underwent serial muscle biopsies during the first year of treatment in order to document the nature and chronology of histological changes during therapy. Inflammatory and necrobiotic changes indicating active myositis resolved within six months in all cases and no patient developed histological evidence of steroid myopathy. Scores on functional muscle strength assessments improved more slowly than static manual muscle strength test results, reflecting morphometric and architectural abnormalities in the biopsies which persisted throughout the period of observation. Serum creatine kinase levels returned to normal more rapidly than serum myoglobin. No statistical relationship was found between muscle strength measurements and biochemical or histological changes within the patients as a group, but variations in these indices in individual subjects reflected changes in clinical state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810311      PMCID: PMC1292163          DOI: 10.1177/014107688908200607

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  18 in total

1.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. I. VARIATIONS IN SERUM CREATINE KINASE ACTIVITY IN NORMAL INDIVIDUALS.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-02       Impact factor: 10.154

2.  An evaluation of some carrier detection techniques in Duchenne muscular dystrophy.

Authors:  R J Lane; P Maskrey; G A Nicholson; P Q Siddiqui; M Nicholson; P Gascoigne; R J Pennington; D Gardner-Medwin; J N Walton
Journal:  J Neurol Sci       Date:  1979-11       Impact factor: 3.181

3.  The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron.

Authors:  M H Brooke; W K Engel
Journal:  Neurology       Date:  1969-04       Impact factor: 9.910

4.  Muscle breakdown and repair in polymyositis: a case study.

Authors:  R H Edwards; C M Wiles; J M Round; M J Jackson; A Young
Journal:  Muscle Nerve       Date:  1979 May-Jun       Impact factor: 3.217

5.  Circulating autoantibody against human myoglobin in polymyositis.

Authors:  M Nishikai; M Homma
Journal:  JAMA       Date:  1977-04-25       Impact factor: 56.272

6.  Muscular strength as an index of response to therapy in childhood dermatomyositis.

Authors:  J S Resnick; M Mammel; M O Mundale; F J Kottke
Journal:  Arch Phys Med Rehabil       Date:  1981-01       Impact factor: 3.966

7.  Serum myoglobin in muscular dystrophy and carrier detection.

Authors:  L V Nicholson
Journal:  J Neurol Sci       Date:  1981-09       Impact factor: 3.181

8.  Azathioprine with prednisone for polymyositis. A controlled, clinical trial.

Authors:  T W Bunch; J W Worthington; J J Combs; D M Ilstrup; A G Engel
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

9.  Muscle biopsy in polymyositis and dermatomyositis: a clinicopathological study.

Authors:  H A Schwarz; G Slavin; P Ward; B M Ansell
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

10.  Radioimmunoassay of serum myoglobin in neuromuscular diseases.

Authors:  H Askmark; P O Osterman; L E Roxin; P Venge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

View more
  3 in total

Review 1.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  I E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  The assessment and importance of disease activity versus disease damage in patients with inflammatory myopathy.

Authors:  Shabina M Sultan
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

Review 3.  Quantitative evaluation of muscle perfusion with CEUS and with MR.

Authors:  Marc-André Weber; Martin Krix; Stefan Delorme
Journal:  Eur Radiol       Date:  2007-04-24       Impact factor: 7.034

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.